Opportunity timeline

PostedOct 27, 2026
DeadlineNov 6, 2026

In plain English

The National Cancer Institute intends to award Plasmidsaurus a sole-source order for RNA and whole-genome sequencing of cell lines and research samples. The work supports lymphoma research, including analysis of gene expression, translocations, and copy number changes. Other capable vendors may email a capability statement to [email protected] by 9:00 a.m. EDT on November 6, 2026; this is not a request for competitive quotes.

About this opportunity

NOTICE OF INTENT – SOLE-SOURCE ACQUISITION Notice No.: 75N98027Q00020 The National Institutes of Health (NIH), National Cancer Ibstitute (NCI), intends to award a Firm-Fixed-Price Purchase Order to Plasmidsaurus Inc. for RNA sequencing and whole genome sequencing services for various wild-type, drug-treated cell lines and samples related to CRISPR research. Description of the Requirement The primary objective of this study is to investigate common lymphoma-related translocations involving MYC, BCL6, or BCL2, while also examining copy number alterations and making CNV calls for genes of interest. To achieve this, RNA sequencing will be provided for samples generated in the Staudt laboratory.…

Time remaining

Closes Nov 6, 2026

08Days
:
08Hours
:
52Min
:
48Sec

Related Opportunities

Bid details are gathered and summarized automatically. Please verify details at the original source.

Ref No.

BS-556FE0